# Rate on a scale of -1 to 11

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/rate-on-a-scale-of-1-to-11/
> **Published:** 2026-03-18T22:44:20-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:05:24-04:00
> **Clinical Summary:** Your pain scale just gained a dimension. Unfortunately, the THC percentages still don&#8217;t correlate with clinical outcomes the way we&#8217;d all like them to. Via r/trees Further Reading Research DigestPM News Update: March 17, 2026 Evidence WatchCannabinoid Clinical Trials: CBD &amp; Cortical Excitability Cannabis Policy WireSchedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene [&hellip;]

---

Your pain scale just gained a dimension. Unfortunately, the THC percentages still don’t correlate with clinical outcomes the way we’d all like them to.

Via [r/trees](https://reddit.com/r/trees/comments/1rxfy77/rate_on_a_scale_of_1_to_11/)

Further Reading
Research Digest[PM News Update: March 17, 2026](https://cedclinic.com/texas-hemp-stricter-thc-rules-march-31-2026/)
Evidence Watch[Cannabinoid Clinical Trials: CBD & Cortical Excitability](https://cedclinic.com/cbd-anti-seizure-properties-cortical-excitability-trial/)
Cannabis Policy Wire[Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I](https://cedclinic.com/scheduling-novel-synthetic-opioids-schedule-i/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
